cycloheximide has been researched along with vorinostat in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bordin, M; Citi, S; D'Atri, F; Guillemot, L | 1 |
Drexler, HC; Euler, M | 1 |
Carew, JS; Cleveland, JL; Courage, JF; Giles, FJ; Houghton, JA; Huang, P; Maclean, KH; McConkey, DJ; Nawrocki, ST | 1 |
3 other study(ies) available for cycloheximide and vorinostat
Article | Year |
---|---|
Histone deacetylase inhibitors up-regulate the expression of tight junction proteins.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3T3 Cells; Animals; Butyrates; Cell Adhesion; Cell Differentiation; COS Cells; Cycloheximide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunoblotting; Isobutyrates; Membrane Proteins; Mice; Microfilament Proteins; Microscopy, Fluorescence; Protein Kinase Inhibitors; Rats; Reverse Transcriptase Polymerase Chain Reaction; Tight Junctions; Up-Regulation; Vorinostat | 2004 |
Synergistic apoptosis induction by proteasome and histone deacetylase inhibitors is dependent on protein synthesis.
Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Butyrates; Caspase 8; Cycloheximide; Enzyme Activation; Enzyme Inhibitors; fas Receptor; Fusion Proteins, bcr-abl; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; K562 Cells; Mice; Mitochondria; Oligopeptides; Proteasome Inhibitors; Protein Biosynthesis; U937 Cells; Vorinostat | 2005 |
Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA.
Topics: Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Nucleus Structures; Cycloheximide; Diploidy; Drug Synergism; Endoplasmic Reticulum; Fibroblasts; Histone Deacetylase 6; Histone Deacetylases; Humans; Hydroxamic Acids; Multiple Myeloma; Protein Biosynthesis; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyrazines; RNA, Small Interfering; Vorinostat | 2008 |